Center-Authored Papers

Filters: Author is Gradishar, William J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Treatment Outcome
Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.  2013.  Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(7):1884-93. Abstract
Thiazoles
Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.  2013.  Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(7):1884-93. Abstract
Risk Factors
Carlson RW, Allred CD, Anderson BO, Burstein HJ, Carter BW, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH et al..  2011.  Invasive breast cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(2):136-222.
Registries
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Receptor, erbB-2
Albain KS, Carey L, Gradishar WJ, Gralow JR, Lipton A, Rugo H, Tripathy D, Peck S, Abair T, Pegram M.  2010.  Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancer.. Clinical breast cancer. 10(6):421-39. Abstract
Qualitative Research
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Pyrimidines
Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.  2013.  Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(7):1884-93. Abstract
Public Health Sciences Division
Carlson RW, Allred CD, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ et al..  2012.  Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(7):821-9. Abstract
Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ et al..  2013.  Breast cancer, version 3.2013: featured updates to the NCCN guidelines.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(7):753-60;quiz761. Abstract
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goldstein LJ et al..  2014.  Breast cancer version 3.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(4):542-90. Abstract
Prognosis
Albain KS, Carey L, Gradishar WJ, Gralow JR, Lipton A, Rugo H, Tripathy D, Peck S, Abair T, Pegram M.  2010.  Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancer.. Clinical breast cancer. 10(6):421-39. Abstract
Problem Solving
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Patient Advocacy
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Outcome Assessment (Health Care)
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Neoplasm Staging
Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.  2013.  Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(7):1884-93. Abstract
Neoplasm Metastasis
Albain KS, Carey L, Gradishar WJ, Gralow JR, Lipton A, Rugo H, Tripathy D, Peck S, Abair T, Pegram M.  2010.  Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancer.. Clinical breast cancer. 10(6):421-39. Abstract
Neoplasm Invasiveness
Carlson RW, Allred CD, Anderson BO, Burstein HJ, Carter BW, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH et al..  2011.  Invasive breast cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(2):136-222.
Middle Aged
Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.  2013.  Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(7):1884-93. Abstract
Maximum Tolerated Dose
Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.  2013.  Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(7):1884-93. Abstract
International Cooperation
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Interdisciplinary Communication
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract
Humans
Carlson RW, Allred CD, Anderson BO, Burstein HJ, Carter BW, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH et al..  2011.  Invasive breast cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(2):136-222.
Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.  2013.  Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(7):1884-93. Abstract
Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV et al..  2011.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.. Breast (Edinburgh, Scotland). 20 Suppl 2:S20-9. Abstract